Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Events    symbols : Teva    save search

Teva to Present at the Barclays Global Healthcare Conference - March 7, 2023
Published: 2023-03-07 (Crawled : 00:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.21% H: 0.43% C: -3.58%

global conference teva
Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting
Published: 2023-02-24 (Crawled : 21:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.2% H: 1.11% C: 0.2%

digihaler system immunology meeting teva study
Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022
Published: 2022-08-29 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.36% H: 0.48% C: -0.63%

proair set teva respiratory trial international
Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
Published: 2022-05-17 (Crawled : 12:20) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: 4.77% H: 4.8% C: 3.32%

research
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.81% H: 4.47% C: 3.3%

proair potential
Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ET on May 3, 2022
Published: 2022-04-04 (Crawled : 21:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 4.75% C: 4.32%

conference results
Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting
Published: 2022-04-01 (Crawled : 18:00) - biospace.com/
TEVJF | News | $12.37 -24.22% 380 twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.64% C: -0.32%

ajovy injection
Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN
Published: 2021-09-30 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.4% C: -2.21%

injection symposium
New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at 2021 American Headache Society (AHS) Annual Meeting
Published: 2021-06-03 (Crawled : 14:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 1.99% C: 0.09%

injection
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva’s Longstanding Heritage in the Management of Migraine
Published: 2021-06-03 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 1.99% C: 0.09%

migraine test injection
Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets
Published: 2021-05-17 (Crawled : 16:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.8% C: 1.8%

skin
Teva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 -0.31% 7.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 1.21% C: 0.56%


Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.